Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Depreciation & Amortization (CF) (2024 - 2025)

Beta Bionics (BBNX) has disclosed Depreciation & Amortization (CF) for 2 consecutive years, with $565000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 101.07% to $565000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 33.33% year-over-year, with the annual reading at $1.6 million for FY2025, 33.33% up from the prior year.
  • Depreciation & Amortization (CF) hit $565000.0 in Q4 2025 for Beta Bionics, up from $385000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $565000.0 in Q4 2025 to a low of $281000.0 in Q4 2024.